SCHEMBL6199824

SCHEMBL6199824

CCOc1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.61
PDE4B Q07343 1/20 0.61
PDE4C Q08493 1/20 0.61
PDE4D Q08499 1/20 0.61
SREBF2 Q12772 4/20 0.60
KDM4E B2RXH2 4/20 0.56
POLB P06746 3/20 0.56
MAPT P10636 3/20 0.56
ATM Q13315 1/20 0.56
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 2/20 0.54
GAA P10253 2/20 0.54
KMT2A Q03164 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
RAB9A P51151 1/20 0.54
CYP1A1 P04798 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2E1 P05181 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C8 P10632 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6201319 0.91 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6194685 0.88 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL7500176 0.88 MAPT (0.72) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6202837 0.87 SREBF2 (0.60) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL7499486 0.86 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DSREBF2
Hydrochloric Acid SCHEMBL6199487 0.86 SREBF2 (0.59) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6201560 0.84 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL8923403 0.84 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DSREBF2
Iodide SCHEMBL6202003 0.84 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL7499471 0.84 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DSREBF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed